Hemoglobin Philly Tyrosine Phenylalanine): Studies ... Hemoglobin Philly (p35 Tyrosine...

download Hemoglobin Philly Tyrosine Phenylalanine): Studies ... Hemoglobin Philly (p35 Tyrosine Phenylalanine):

of 16

  • date post

    05-Jun-2018
  • Category

    Documents

  • view

    213
  • download

    0

Embed Size (px)

Transcript of Hemoglobin Philly Tyrosine Phenylalanine): Studies ... Hemoglobin Philly (p35 Tyrosine...

  • Hemoglobin Philly (p35 Tyrosine Phenylalanine):

    Studies in the Molecular Pathology of Hemoglobin

    RONALD F. RIEDER, FRANK A. OsKI, and J. B. CLEGG

    From the Department of Medicine, State University of New York, DownstateMedical Center, Brooklyn, New York 11203; Department of Pediatrics, Schoolof Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104;Nuffield Unit of Medical Genetics, Department of Medicine, University ofLiverpool, Liverpool, Great Britain

    A B S T R A C T An abnormal unstable hemoglobin, he-moglobin Philly, was found in three members of a fam-ily, each of whom had evidence of a chronic hemolyticstate. The presence of the mutant protein was sug-gested by the rapid appearance of inclusion bodies uponincubation of erythrocytes with brilliant cresyl blue andby the increased heat precipitability of the hemoglobin.However, no abnormal hemoglobin could be demon-strated by electrophoresis or column chromatography.Sulfhydryl titration of the hemolysates with p-mercuri-benzoate indicated that there was an average of fourreactive sulfhydryl groups per hemoglobin molecule in-stead of the usual two. The total number of hemoglobinsulfhydryl groups was normal; six groups were mea-sured when denatured globin was reacted with 5,5'-dithi-obis [2-nitrobenzoic acid]. This indicated that the in-creased sulfhydryl reactivity was due to an increasedavailability to p-mercuribenzoate of the usually unreac-tive hemoglobin cysteines at u112 and a104. After treat-ment for i hr with 4-5 moles of p-mercuribenzoate permole of hemoglobin, electrophoresis revealed that 30-35%of the hemoglobin had been dissociated into a- andf-chains. Normal hemolysates revealed negligible split-ting after 72 hr of similar treatment. The a- and f-chainsof hemoglobin Philly were separated from the unsplithemoglobin A by carboxymethyl cellulose chromatog-raphy. Fingerprint and amino acid analyses revealedthat tyrosine #35 was replaced by phenylalanine. In he-moglobin Philly there is loss of the normal hydrogenbond between the tyrosine hydroxyl group and the car-boxyl group of aspartic acid a126 at the aifli contact.This shifts the equilibrium from hemoglobin tetramerstoward monomers, exposing the f112 and a104 cysteines.In the cell, precipitation of the unstable monomers maycontribute to erythrocyte destruction.

    Received for publication 24 January 1969.

    INTRODUCTIONThe severity of the clinical manifestations of the dif-ferent abnormal hemoglobins is varied. Many of thesemutant proteins produce no discernible effect on thepatient, while some cause a mild compensated hemolysis,and others are associated with severe hemolytic disease(1). The detection of an abnormal hemoglobin in manypatients presenting with clinical states within thisspectrum has frequently been straightforward. Since thedemonstration of hemoglobin S (2), the widespread useof electrophoresis has resulted in the discovery of over100 mutant forms of human hemoglobin (3).

    Recently it has become evident that a proportion ofpatients with hereditary nonspherocytic hemolytic diseaseof the Heinz body type possess an abnormal unstablehemoglobin (4). In several instances the electrophoreticor chromatographic separation of a variant protein fromhemoglobin A has been difficult or only partially suc-cessful (3). Where complete chemical analyses havebeen performed, several of the mutations have beenshown to consist of amino acid substitutions involvingno change in charge or occurring in the interior of thehemoglobin molecule, so that surface charge and elec-trophoretic mobility are unaffected (3).The present report describes a hemoglobinopathy

    which was discovered in three members of a family, eachof whom had evidence of a chronic hemolytic state.The demonstration of a mutant hemoglobin was ham-pered by the inability to separate a variant protein fromhemoglobin A by any of the usual methods of electro-phoresis or chromatography. Proof of the presence ofhemoglobin Philly, and its isolation and purification, de-pended upon a unique property of this new abnormal he-moglobin.The properties of hemoglobin Philly have provided an

    explanation for the pathophysiologic state of the affected

    The Journal of Clinical Investigation Volume 48 1969 1627

  • patients. The structural defect of the abnormal hemoglo-bin has provided information on the importance of oneinterchain bond in the maintenance of the structural in-tegrity of the normal hemoglobin molecule.

    METHODSHandling of blood samples. Routine hematologic exami-

    nations by standard methods (5) and enzyme assays wereperformed on heparinized freshly drawn venous blood speci-mens. Other studies were done on samples anticoagulated andmailed packed in ice. Transit time was approximately 1 day.Preparation of hemolysates. Erythrocytes were washed

    three to five times with 0.9% NaCl. For studies of hemo-globin, hemolysis was effected by shaking the cells with anequal volume of distilled water and i volume of carbontetrachloride or by stirring with 4 volumes of distilled waterfollowed by the addition of adequate 4 N NaCl to restore thesodium concentration to 0.15 N. Stroma was removed bycentrifugation.Erythrocyte enzyme assays. Hemolysates were prepared

    by diluting the washed red cell suspension 1:10 in distilledwater. Hexokinase, phosphoglucose isomerase, phosphofruc-tokinase, aldolase, triose phosphate isomerase, phospho-glycerate mutase, enolase, and lactic dehydrogenase wereassayed by previously described methods (6) with tri-ethanolamine buffer, pH 8.0, at a final concentration of 0.1moles/liter. Phosphoglycerate kinase was assayed as de-scribed by Loder and De Gruchy (7), glyceraldehyde-3-phosphate dehydrogenase as described by Schrier (8), andglucose-6-phosphate dehydrogenase by the method of Zink-ham and Lenhard (9). Pyruvate kinase was measured bythe procedure of Rose and Warms (10) with phosphoenol-pyruvate in a final concentration of 2.0 mmoles/liter and aden-osine diphosphate (ADP) at 1.5 mmoles/liter. Glutathionereductase was assayed according to the method of Horn (11).

    Effect of redox dye ont erythrocytes and hemoglobin. Onepart of a 1% solution of brilliant cresyl blue, in 0.9% sodiumchloride was added to two parts of heparinized blood. Thismixture was incubated at 370C, and blood films were pre-pared at intervals over the next 24 hr.

    Other studies. Methemoglobin was measured by themethod of Evelyn and Malloy (12) on fresh hemolysatesand after 24 hr of incubation at 370C. The heat stability ofhemoglobin was tested, with and without the addition ofNaCN, according to the procedure of Grimes, Meisler, andDacie (13). The technique of Betke, Marti, and Schlicht wasused to assay alkali-resistant hemoglobin (14). The ferro-hemoglobin solubility test was performed according toItano (15).

    Ultracentrifuge studies. Sedimentation analyses weremade with a Spinco model E ultracentrifuge at 52,000 rpmand 4VC. Measurements were made on Schlieren photographsobtained using a No. 29 Wratten filter and 1 N spectro-scopic plates.

    Electrophoresis. Standard methods were employed forhemoglobin electrophoresis on starch gel (16), agar gel (17),and starch block (18). The method of Chernoff and Pettitwas utilized for the electrophoresis of globin polypeptidechains on starch gel in urea-containing buffers (19).Column chromatography. Column chromatography of

    hemoglobin solutions on carboxymethyl cellulose (CMC) andon Amberlite CG-50 was performed according to previouslydescribed methods (20, 21).

    Sulfhydryl determinations. The reactive sulfhydryl groupsof hemoglobin were measured spectrophotometrically by

    titration with p-mercuribenzoate (PMB) according to themethod of Boyer (22) as modified by Benesch and Benesch(23). Total sulfhydryl groups in denatured globin prepara-tions were measured by the method of Ellman (24) using5,5'-dithiobis[2-nitrobenzoic acid] (DTNB), as describedby Guidotti (25).

    Preparation of a- and 8-chains of hemoglobin. The heme-bearing PMB derivatives of the chains of hemoglobin A wereprepared by reacting the protein with a twelvefold molarexcess of PMB at pH 6.2, according to the method of Bucciand Fronticelli (26) as modified by Rosemeyer and Huehns(27). Isolation of the a-PMB and 8-PMB chains was thenachieved by CMC chromatography or starch-block electro-phoresis.

    Fingerprint analysis. Heme was removed from the PMBderivatives of hemoglobin a- and ,8-chains by the acid-acetonemethod (28). PMB was removed from the globin by dis-solving the lyophilized protein in nitrogen-saturated 8 Murea containing 0.3 M 2-mercaptoethanol and allowing themixture to stand at room temperature for 3 hr under ni-trogen. The protein was subsequently separated from thelow molecular weight materials by passage through aSephadex G25 column equilibrated with 0.5% formic acid.Regeneration of sulfhydryl groups was checked using DTNB.Aminoethylation and trypsin digestion were carried out aspreviously described (29). High voltage paper electrophoresisof the tryptic digests was done with pyridine-acetic acid-water buffers at pH 4.7 and 6.4. The chromatography stepof the two-dimensional fingerprints was performed usingsolvent systems composed of pyridine-isoamyl alcohol-water, 35: 35: 37, or butanol-acetic acid-pyridine-water,15: 3:10:12. Automatic amino acid analyses were done onmaterial eluted from the fingerprints and hydrolysed in 6 NHCl containing 1 mg of phenol per ml in order to preventloss of tyrosine.

    Materials. Sigma Chemical Co., St. Louis, Mo., providedPMB sodium salt, cystamine (2,2'-dithiobis[ethylamine dihy-drochloride], DTNB, and iodoacetamide. Iodoacetanmide-1-J'C,0.05 mc in 4.2 mg, was obtained from New England NuclearCorp., Boston, Mass.

    RESULTSClinical data and case report. The propositus (II-1)

    (Table I), a 9 yr old girl of Italian and German-Frenchancestry, was originally